Title: Adverse outcome pathways: hype or hope?
Authors: VINKEN MathieuWHELAN MauriceROGIERS Vera
Citation: ARCHIVES OF TOXICOLOGY vol. 88 no. 1 p. 1-2
Publisher: SPRINGER HEIDELBERG
Publication Year: 2014
JRC N°: JRC83526
ISSN: 0340-5761
URI: http://link.springer.com/article/10.1007%2Fs00204-013-1093-6
http://publications.jrc.ec.europa.eu/repository/handle/JRC83526
DOI: 10.1007/s00204-013-1093-6
Type: Articles in periodicals and books
Abstract: Toxicity testing typically focuses on generating data concerning the adverse effects of chemical substances on human health or the environment. However, there is an increasing desire to go beyond observation and prioritize the elucidation of the molecular machinery that drives the manifestation of toxicological apical endpoints (Andersen et al., 2012). This view was clearly embodied with the introduction of so-called toxicity pathways, which denote cellular response cascades that, when sufficiently perturbed, are expected to result in an adverse health outcome (NRC, 2007; OECD, 2012a).
JRC Directorate:Institute for Health and Consumer Protection Historical Collection

Files in This Item:
There are no files associated with this item.


Items in repository are protected by copyright, with all rights reserved, unless otherwise indicated.